Whales with a lot of money to spend have taken a noticeably bullish stance on Boston Scientific.
Looking at options history for Boston Scientific BSX we detected 8 trades.
If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish expectations and 37% with bearish.
From the overall spotted trades, 3 are puts, for a total amount of $237,557 and 5, calls, for a total amount of $280,235.
What's The Price Target?
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $75.0 and $85.0 for Boston Scientific, spanning the last three months.
Volume & Open Interest Trends
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Boston Scientific's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Boston Scientific's whale trades within a strike price range from $75.0 to $85.0 in the last 30 days.
Boston Scientific Option Activity Analysis: Last 30 Days
Significant Options Trades Detected:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BSX | PUT | SWEEP | BULLISH | 07/19/24 | $1.7 | $1.55 | $1.55 | $77.50 | $155.0K | 699 | 1.0K |
| BSX | CALL | SWEEP | BEARISH | 07/19/24 | $2.05 | $2.0 | $2.0 | $77.50 | $99.6K | 614 | 809 |
| BSX | CALL | SWEEP | BULLISH | 06/21/24 | $1.45 | $1.1 | $1.25 | $77.50 | $82.7K | 6.4K | 1.0K |
| BSX | PUT | SWEEP | BULLISH | 08/16/24 | $1.45 | $1.4 | $1.4 | $75.00 | $51.8K | 467 | 378 |
| BSX | CALL | SWEEP | BULLISH | 07/19/24 | $2.0 | $1.95 | $1.95 | $77.50 | $43.4K | 614 | 311 |
About Boston Scientific
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
In light of the recent options history for Boston Scientific, it's now appropriate to focus on the company itself. We aim to explore its current performance.
Boston Scientific's Current Market Status
- With a trading volume of 2,923,012, the price of BSX is up by 1.54%, reaching $77.29.
- Current RSI values indicate that the stock is may be overbought.
- Next earnings report is scheduled for 48 days from now.
What The Experts Say On Boston Scientific
A total of 4 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $90.5.
- An analyst from Citigroup persists with their Buy rating on Boston Scientific, maintaining a target price of $87.
- Maintaining their stance, an analyst from Argus Research continues to hold a Buy rating for Boston Scientific, targeting a price of $95.
- Reflecting concerns, an analyst from Goldman Sachs lowers its rating to Buy with a new price target of $90.
- An analyst from Mizuho has decided to maintain their Buy rating on Boston Scientific, which currently sits at a price target of $90.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Boston Scientific, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
